Maturing the internal controls system at FDA blanket purchase agreement (BPA)

Ended Awarded Last action

Contract number
75F40121F19005
Awardee
Awarding agency
Obligated
$6,494,716

Award facts

Opportunity
  • 1238945 Solicitation number
Contract value 61% obligated
  • $6,494,715.67 Current, with exercised options
  • $10,721,691.46 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Arlington, VA 22209, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00018 $0
Other Administrative Action P00017 -$873,979
Other Administrative Action P00016 · EOI::final settlement payment::EOI termination for convenience agreement -$278,084
Other Administrative Action P00015 $0
Other Administrative Action P00014 -$5,127
Other Administrative Action P00013 · Tasks 1 through 8, task support for a-123 internal control assessments $1,430,148
Other Administrative Action P00012 $0
Other Administrative Action P00011 · Optional task 9: organizational risk reviews $418,961
Other Administrative Action P00010 $0
Other Administrative Action P00009 $0
Other Administrative Action P00008 $1,368,513
Other Administrative Action P00007 $664,570
Other Administrative Action P00006 $0
Other Administrative Action P00005 $1,334,354
Other Administrative Action P00004 $294,420
Exercise an Option P00003 $1,597,287
Change Order P00002 -$104,978
Supplemental Agreement for work within scope P00001 $0
Original award $648,630
Show all 19

About this award

The Food and Drug Administration issued a BPA call to Deloitte & Touche LLP on September 17, 2021, under the Maturing the Internal Controls System at FDA Blanket Purchase Agreement, with a ceiling value of $10.7 million and an ultimate completion date of July 7, 2026. The call, terminating for convenience as of that date, supported FY 2021 A-123 internal controls assessments. Place of performance is Arlington, Virginia.

The call delivered task support for FDA's internal control maturation and assessment program on a firm fixed price basis. Service Contract Inventory reporting shows the prime invoiced $1.6 million in FY2022 across 7.4 FTEs and 15,464 contractor hours; $1.7 million in FY2023 across 6.7 FTEs and 13,974 contractor hours; $1.9 million in FY2024 across 5.6 FTEs and 11,604 contractor hours; and $1.3 million in FY2025 across 2.3 FTEs. Derived government-paid hourly rates rose from $104.02 per hour in FY2022 to $163.95 per hour in FY2024, reflecting a rising pricing trend. The prime self-performed all reported hours in FY2025 with no subcontractors.

Quick answers

Who was awarded contract 75F40121F19005?

75F40121F19005 was awarded to Deloitte & Touche LLP by Food and Drug Administration (Department of Health and Human Services) on September 17, 2021.

How much is contract 75F40121F19005 worth?

The government has obligated $6,494,716 on 75F40121F19005. Its potential value, with all options, is $10,721,691.

Is contract 75F40121F19005 an order under another contract?

Yes. 75F40121F19005 is a BPA call under GS00F029DA-75F40120A00023, a blanket purchase agreement, on Multiple Award Schedule (MAS).

Was contract 75F40121F19005 competed?

The extent of competition for 75F40121F19005 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award